Aβ increases GFAP levels in the hippocampus (Meunier et al., 2015), and GFAP is upregulated in astrocytes of patients with AD (Perez-Nievas and Serrano-Pozo, 2018), which initiates neuroinflammation and cellular damage. This evidence concerns the gene GFAP and Alzheimer disease.